EUVIMEDEUVIMED entdecken
Crossref

ZFP36L1 Promotes Gastric Cancer Progression via Regulating JNK and p38 MAPK Signaling Pathways

Kang Ding, Fengping Zhang, Gaoxiu Qi, Meng Lin, Min Chen, Yanchun Chen, Jie Zheng, Fenghua Zhou

Recent Patents on Anti-Cancer Drug Discovery · 2023-02 · 18 (1) · 80-91

DOI: 10.2174/1574892817666220524102403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Recent Patents on Anti-Cancer Drug Discovery, 2023-02. Verfasst von Kang Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Weifang Medical University, Weifang, Shandong, P.R. China. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Shandong Province National Natural Science Foundation, Foundation Key Project of Shandong Province Higher Educational Science and Technology Program of China, Support Program for Youth Innovation technology in Colleges and Universities of Shandong Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The RNA-binding protein Zinc Finger Protein 36 like 1(ZFP36L1) plays an important role in regulating the AU-rich elements (AREs) in the 3′ untranslated region (3′ UTR) of mRNAs, indicating a potential link between its expression and cancers. However, the role and mechanism of ZFP36L1 in gastric cancer (GC) are unclear.

Objective

This study aimed to explore the role and mechanism of ZFP36L1 in gastric cancer. Material and Method: GC tissue samples and matched normal gastric tissues were collected, and the ZFP36L1 expression in these samples was evaluated by immunohistochemistry analysis. GC cells with different differentiation were selected for in vitro experiments. The ZFP36L1 expression in GC cells was examined by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot analysis. The viability and invasiveness of GC cells were assayed by 5-Ethynyl-2-deoxyuridine (EdU) and Transwell assays, respectively. Western blot assay was used to detect the expression of epithelial-to-mesenchymal transition (EMT) related proteins and proteins of the c-Jun N-terminal kinase (JNK) and p38 Mitogen-Activated Protein Kinase (MAPK) signaling pathways.

Results

ZFP36L1 is overexpressed in GC tissues. Patients with high ZFP36L1 expression have a poor prognosis. Moreover, ZFP36L1 is overexpressed in the cell lines with a high degree of malig-nancy. ZFP36L1 increases cell proliferation, invasion, and migration in vitro. Furthermore, ZFP36L1 induces EMT. The JNK inhibitor and p38 inhibitor alone or in combination affect the biological function of GC cells. Furthermore, ZFP36L1 promotes GC progression by inhibiting JNK and p38 MAPK signaling pathways.

Conclusion

RNA-binding protein ZFP36L1 exerts a role in the occurrence of gastric cancer by the regulation of the JNK and p38 MAPK signaling pathways. The combination of inhibitors of the JNK and p38 MAPK signaling pathways could be a novel treatment strategy for gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHumansRNA-Binding ProteinsSignal TransductionButyrate Response Factor 1

Stichwörter der Autor:innen

EMTGastric cancerJNK pathwayZFP36L1inhibitorp38 MAPK pathwayprogression

Substanzen

RNA-Binding ProteinsZFP36L1 protein, humanButyrate Response Factor 1

Autor:innen und Institutionen

  • Department of Pathology, Weifang Medical University, Weifang, Shandong, P.R. China.
  • Department of Pathology, Affiliated hospital, Weifang Medical University, Weifang, Shandong, PR China.
  • Department of Pathology, Affiliated Hospital, Weifang Medical University, Weifang, Shandong, PR China.
  • Department of Histology and Embryology, Weifang Medical University, Weifang, Shandong, P.R. China.

Förderung

  • Shandong Province National Natural Science Foundation
  • Foundation Key Project of Shandong Province Higher Educational Science and Technology Program of China
  • Support Program for Youth Innovation technology in Colleges and Universities of Shandong Province of China
  • National Science Foundation of China
  • Shandong medical and health science and technology development plan project

Zitieren

APA

Ding, K., Zhang, F., Qi, G., Lin, M., Chen, M., Chen, Y., Zheng, J., & Zhou, F. (2023). ZFP36L1 Promotes Gastric Cancer Progression via Regulating JNK and p38 MAPK Signaling Pathways. Recent Patents on Anti-Cancer Drug Discovery, 18(1), 80-91. https://doi.org/10.2174/1574892817666220524102403

Vancouver

Ding K, Zhang F, Qi G, Lin M, Chen M, Chen Y, et al. ZFP36L1 Promotes Gastric Cancer Progression via Regulating JNK and p38 MAPK Signaling Pathways. Recent Patents on Anti-Cancer Drug Discovery. 2023;18(1):80-91. doi:10.2174/1574892817666220524102403

BibTeX
@article{Ding2023,
  author = {Ding, Kang and Zhang, Fengping and Qi, Gaoxiu and Lin, Meng and Chen, Min and Chen, Yanchun and Zheng, Jie and Zhou, Fenghua},
  title = {ZFP36L1 Promotes Gastric Cancer Progression via Regulating JNK and p38 MAPK Signaling Pathways},
  journal = {Recent Patents on Anti-Cancer Drug Discovery},
  year = {2023},
  volume = {18},
  number = {1},
  pages = {80--91},
  doi = {10.2174/1574892817666220524102403}
}
Kostenlos starten →